ARCHIVES

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

November 25, 2011

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983

Advisors’ Report On Intramural Program To Recommend Restructuring

April 14, 1995

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012